TRV GP V
Boston, MAfiles as TRV GP V, LLC
$498m in 3 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 4.5% of the portfolio this quarter.
Value
$498m
Stocks
3
Top 10 share
100.0%
Turnover
4.5%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
- Rapport TherapeuticsRAPP52.5% of the fund-12%
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Rapport TherapeuticsRAPP | 52.5% | $262m | 6,280,525 | -12% |
| SepternaSEPN | 41.8% | $208m | 6,215,591 | Held |
| Maze TherapeuticsMAZE | 5.7% | $28m | 950,800 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 200.8% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.